US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
CS264222B1
(en)
|
1986-07-18 |
1989-06-13 |
Holy Antonin |
N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
|
AU8092587A
(en)
|
1986-11-18 |
1988-05-19 |
Bristol-Myers Squibb Company |
Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
|
IL84477A
(en)
|
1986-11-18 |
1995-12-08 |
Bristol Myers Squibb Co |
History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them
|
US5650510A
(en)
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
EP0405748A1
(en)
|
1989-05-30 |
1991-01-02 |
Beecham Group p.l.c. |
Phosphonoderivative of purine with antiviral activity
|
DE69110528T2
(de)
|
1990-04-20 |
1996-03-14 |
Inst Of Organic Chemistry And |
Chirale 2-(Phosphonomethoxy)propyl-Guanine als antivirale Agentien.
|
SK280313B6
(sk)
|
1990-04-24 |
1999-11-08 |
�Stav Organick� Chemie A Biochemie Av �R |
N-(3-fluór-2-fosfonylmetoxypropyl)deriváty purínov
|
AU651835B2
(en)
|
1990-06-13 |
1994-08-04 |
Arnold Glazier |
Phosphorous prodrugs
|
CS276072B6
(en)
|
1990-08-06 |
1992-03-18 |
Ustav Organicke Chemie A Bioch |
(2R)-2-/DI(2-PROPYL)PHOSPHONYLMETHOXY/-3-p-TOLUENESULFONYLOXY -1- TRIMETHYLACETOXYPROPANE AND PROCESS FOR PREPARING THEREOF
|
KR100221981B1
(ko)
|
1990-08-10 |
1999-09-15 |
안토닌 포레이트 |
뉴클레오티드의 신규 제조방법
|
ATE167679T1
(de)
|
1990-09-14 |
1998-07-15 |
Acad Of Science Czech Republic |
Wirkstoffvorläufer von phosphonaten
|
GB9020932D0
(en)
|
1990-09-26 |
1990-11-07 |
Wellcome Found |
Heterocyclic compounds
|
GB9026164D0
(en)
|
1990-12-01 |
1991-01-16 |
Beecham Group Plc |
Pharmaceuticals
|
CZ284678B6
(cs)
|
1991-05-20 |
1999-01-13 |
Ústav Organické Chemie A Biochemie Avčr |
Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
|
EP0531597A1
(en)
|
1991-09-12 |
1993-03-17 |
Merrell Dow Pharmaceuticals Inc. |
Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
|
CA2120743C
(en)
|
1991-10-11 |
2005-03-08 |
John C. Martin |
Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
|
GB9205917D0
(en)
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
US5837453A
(en)
|
1992-05-13 |
1998-11-17 |
Geron Corporation |
Telomerase activity assays
|
US5629154A
(en)
|
1993-11-12 |
1997-05-13 |
Geron Corporation |
Telomerase activity assays
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
US5532225A
(en)
|
1992-07-31 |
1996-07-02 |
Sri International |
Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5817647A
(en)
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
EP0618214A1
(en)
|
1993-04-01 |
1994-10-05 |
Merrell Dow Pharmaceuticals Inc. |
Unsaturated phosphonate derivatives of purines and pyrimidines
|
CA2126601A1
(en)
|
1993-06-29 |
1994-12-30 |
Mitsubishi Chemical Corporation |
Phosphonate-nucleotide ester derivatives
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
BR9407510A
(pt)
|
1993-09-17 |
1997-01-07 |
Gilead Sciences Inc |
Análogos de nucleotideo
|
US5863726A
(en)
|
1993-11-12 |
1999-01-26 |
Geron Corporation |
Telomerase activity assays
|
EP0754046A1
(en)
|
1994-04-04 |
1997-01-22 |
FREEMAN, William R. |
Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
|
US5583016A
(en)
|
1994-07-07 |
1996-12-10 |
Geron Corporation |
Mammalian telomerase
|
US5958680A
(en)
|
1994-07-07 |
1999-09-28 |
Geron Corporation |
Mammalian telomerase
|
IT1270008B
(it)
|
1994-09-23 |
1997-04-16 |
Ist Superiore Sanita |
Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
|
JP3906488B2
(ja)
|
1995-02-21 |
2007-04-18 |
味の素株式会社 |
プリン誘導体の製造方法
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
CA2224710A1
(en)
|
1995-06-15 |
1997-01-03 |
Naoko Inoue |
Phosphonate nucleotide derivatives
|
TW369536B
(en)
|
1996-01-18 |
1999-09-11 |
Mitsubishi Chem Corp |
Phosphonate nucleotide compounds
|
US5874577A
(en)
|
1996-04-03 |
1999-02-23 |
Medichem Research, Inc. |
Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
CN1085673C
(zh)
|
1996-08-13 |
2002-05-29 |
三菱化学株式会社 |
膦酸酯-核苷酸化合物
|
US6444650B1
(en)
|
1996-10-01 |
2002-09-03 |
Geron Corporation |
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
US6252061B1
(en)
|
1998-03-23 |
2001-06-26 |
Reliable Biopharmaceutical, Inc. |
Process for the production of 2-halo-6-aminopurine derivatives
|
SI20022A
(sl)
|
1998-07-29 |
2000-02-29 |
Kemijski inštitut |
Alkilno substituirani purinovi derivati in njihova priprava
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6995145B1
(en)
|
1999-06-04 |
2006-02-07 |
Au Jessie L-S |
Methods and compositions for modulating drug activity through telomere damage
|
WO2001018015A1
(en)
|
1999-09-10 |
2001-03-15 |
Geron Corporation |
Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use
|
ES2218216T3
(es)
|
1999-09-24 |
2004-11-16 |
Shire Biochem Inc. |
Analogos de nucleosidos de dioxolano para el tratamiento o la prevencion de infecciones viricas.
|
EP1233770B1
(en)
|
1999-12-03 |
2008-02-13 |
The Regents of The University of California at San Diego |
Phosphonate compounds
|
IL150059A0
(en)
|
1999-12-17 |
2002-12-01 |
Ariad Pharma Inc |
Novel heterocycles
|
CA2396276A1
(en)
|
2000-01-07 |
2001-07-12 |
Universitaire Instelling Antwerpen |
Purine derivatives, process for their preparation and use thereof
|
US6767900B2
(en)
|
2000-02-29 |
2004-07-27 |
Mitsubishi Pharma Corporation |
Phosphonate nucleotide compound
|
PT1301519E
(pt)
|
2000-07-21 |
2015-06-11 |
Gilead Sciences Inc |
Profármacos de análogos de nucleótidos de fosfonato e métodos para selecionar e preparar os mesmos
|
WO2002069949A2
(en)
*
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
KR20020097384A
(ko)
|
2001-06-20 |
2002-12-31 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
|
WO2003028737A1
(en)
|
2001-08-30 |
2003-04-10 |
Mitsubishi Pharma Corporation |
Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon
|
IL161901A0
(en)
|
2001-11-14 |
2005-11-20 |
Biocryst Pharmaceuticals Inc A |
Nucleosides, preparation thereof and use as inhibiDevice for the reading and the signalling of environmental parameters tors of rna viral polymerases
|
US6858393B1
(en)
|
2002-03-13 |
2005-02-22 |
Stratagene California |
Chain terminators for DNA synthesis
|
AU2003224836A1
(en)
|
2002-04-12 |
2003-10-27 |
Stratagene |
Dual-labeled nucleotides
|
CA2485702C
(en)
|
2002-05-13 |
2011-07-19 |
Metabasis Therapeutics, Inc. |
Novel phosphonic acid based prodrugs of pmea and its analogues
|
TW200402299A
(en)
|
2002-05-24 |
2004-02-16 |
Mitsubishi Pharma Corp |
Drugs improved in tissue selectivity
|
WO2004043402A2
(en)
|
2002-11-12 |
2004-05-27 |
Pharmasset, Inc. |
Modified nucleosides as antiviral agents
|
DK1583542T3
(da)
|
2003-01-14 |
2008-09-22 |
Gilead Sciences Inc |
Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
|
AU2003234563A1
(en)
|
2003-05-14 |
2005-01-21 |
Biocryst Pharmaceutical, Inc. |
Nucleoside analogs as viral polymerase inhibitors
|
SI1644389T1
(sl)
|
2003-06-16 |
2011-06-30 |
Acad Of Science Czech Republic |
Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
|
AU2004260789B2
(en)
|
2003-07-30 |
2011-06-30 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
EP1664046B1
(en)
|
2003-09-19 |
2009-06-17 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
SG149075A1
(en)
*
|
2003-12-30 |
2009-01-29 |
Gilead Sciences Inc |
Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
US8063209B2
(en)
|
2004-07-02 |
2011-11-22 |
Tsrl, Inc. |
Phosphonyl ester conjugates as prodrugs
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
ITFI20040173A1
(it)
|
2004-08-03 |
2004-11-03 |
Protera S R L |
Profarmaci attivati da dna polimerasi dipendenti da rna
|
WO2006066074A2
(en)
*
|
2004-12-16 |
2006-06-22 |
The Regents Of The University Of California |
Lung-targeted drugs
|
WO2006104975A2
(en)
|
2005-03-25 |
2006-10-05 |
Alt Solutions, Inc. |
Modulation of telomere length in telomerase positive cells and cancer therapy
|
WO2006130217A2
(en)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
ES2261072B1
(es)
|
2005-04-06 |
2007-12-16 |
Consejo Superior Investig. Cientificas |
Fosforotioatos derivados de analogos a nucleosido para terapia antirretroviral.
|
AU2006239677A1
(en)
*
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
WO2006125166A2
(en)
|
2005-05-18 |
2006-11-23 |
Alt Solutions, Inc. |
Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
|
WO2007002912A2
(en)
*
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-proliferative compounds, compositions, and methods of use thereof
|
WO2007014491A1
(fr)
|
2005-08-03 |
2007-02-08 |
Beijing Fu Kang Ren Bio-Pharm Tech.Co.Ltd. |
Phosphonates de nucléotides acycliques et leur utilisation dans des agents antiviraux
|
WO2007106450A2
(en)
|
2006-03-10 |
2007-09-20 |
University Of Georgia Research Foundation, Inc. |
Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy
|
ES2600792T3
(es)
|
2006-05-03 |
2017-02-10 |
Chimerix, Inc. |
Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
|
US20090232024A1
(en)
|
2006-06-30 |
2009-09-17 |
Panasonic Corporation |
Node discovery method for providing optimal path preserving location privacy
|
WO2008005555A1
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
FR2908133B1
(fr)
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
EP2155257B1
(en)
|
2007-04-27 |
2016-10-05 |
Chimerix, Inc. |
Methods of reducing nephrotoxicity in subjects administered with nucleoside
|
WO2008134578A2
(en)
|
2007-04-28 |
2008-11-06 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
Synthesis of optically active radio-labeled reverse transcriptase inhibitors
|
GB0709408D0
(en)
|
2007-05-16 |
2007-06-27 |
Katholleke Universiteit Leuven |
Anti-col herpes virus compounds
|
CA2713105C
(en)
|
2008-01-25 |
2016-06-07 |
Chimerix, Inc. |
Methods of treating viral infections
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
WO2009115927A2
(en)
|
2008-03-18 |
2009-09-24 |
Institut De Recherches Cliniques De Montreal |
Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
|
US20100081713A1
(en)
|
2008-03-19 |
2010-04-01 |
CombinatoRx, (Singapore) Pte. Ltd. |
Compositions and methods for treating viral infections
|
US20110059921A1
(en)
|
2008-03-27 |
2011-03-10 |
Ektar Therapeutics |
Oligomer-Nitrogenous Base Conjugates
|
CA2721586A1
(en)
|
2008-04-15 |
2009-10-22 |
Mallinckrodt Inc. |
Compositions containing antiviral compounds and methods of using the same
|
JP5798918B2
(ja)
|
2008-08-21 |
2015-10-21 |
ナインポイント メディカル, インコーポレイテッド |
薬物評価および局所処置のためのデバイスおよび方法
|
JP2012517443A
(ja)
|
2009-02-06 |
2012-08-02 |
アールエフエス ファーマ,エルエルシー |
癌及びウイルス感染の治療のためのプリンヌクレオシド一リン酸プロドラッグ
|
WO2011011710A1
(en)
|
2009-07-24 |
2011-01-27 |
Chimerix, Inc. |
Methods of treating viral infections
|
CA2770282A1
(en)
|
2009-08-03 |
2011-02-10 |
Chimerix, Inc. |
Composition and methods of treating viral infections and viral induced tumors
|
CA2779473C
(en)
|
2009-10-30 |
2016-08-16 |
Chimerix, Inc. |
Methods of treating viral associated diseases
|
KR20120094098A
(ko)
|
2009-12-07 |
2012-08-23 |
유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 |
피리디논 하이드록시사이클로펜틸 카복사미드: 치료 용도의 hiv 인테그라제 억제제
|
CN102093422B
(zh)
|
2009-12-10 |
2015-02-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
无环核苷膦酸酯衍生物及其医药用途
|
US20130028920A1
(en)
|
2010-03-31 |
2013-01-31 |
Universite De Geneve |
Stabilized antibody preparations and uses thereof
|
EP2558466A4
(en)
|
2010-04-14 |
2013-11-13 |
Univ California |
PHOSPHONATES HAVING REDUCED TOXICITY FOR THE TREATMENT OF VIRAL INFECTIONS
|
US8940313B2
(en)
|
2010-04-23 |
2015-01-27 |
University Of Southern California |
Tyrosine-based prodrugs of antiviral agents
|
US9029344B2
(en)
|
2010-06-18 |
2015-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Linked purine pterin HPPK inhibitors useful as antibacterial agents
|
CZ201126A3
(cs)
*
|
2011-01-18 |
2012-05-09 |
Ústav organické chemie a biochemie Akademie ved CR, v.v.i. |
Zpusob výroby substituovaných diamidu fosfonových kyselin
|